The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?
Yıl: 2020 Cilt: 30 Sayı: 2 Sayfa Aralığı: 67 - 75 Metin Dili: İngilizce DOI: 10.4274/tjcd.galenos.2020.2020-4-11 İndeks Tarihi: 13-01-2022
The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?
Öz: The treatment of colorectal cancer, which is an important cause of cancer related death and is still an important public health problem, has become a matter of debate due to the COVID-19 pandemic that emerged in December 2019. This pandemic has forced us to rearrange our entire surgical practice. However, during these arrangements it should be ensured that patients are less affected by the pandemic, hospital resources should be used more efficiently and the risk of healthcare professionals should be minimized. This study discusses how to plan the multimodal treatment of colorectal cancer during the pandemic by using surgical, chemotherapeutic, and radiotherapeutic options while evaluating tailored treatments and the current international guidelines.
Anahtar Kelime: COVID-19 Pandemisi ve Kolorektal Kanser : 5N1K- Neyi, Neden, Nasıl, Nerede, Ne Zaman ve Kime Yapalım?
Öz: Kansere bağlı ölümlerin önemli bir nedeni olan ve halen önemli bir toplum sağlığı sorunu olan kolorektal kanserin tedavisi, Aralık 2019’da ortaya çıkan COVID-19 pandemisi nedeniyle tartışma konusu halini almıştır. Yapılacak düzenlemeler hastaların pandemiden daha az etkilenmesini, hastane kaynaklarının pandemi için daha etkili kullanılmasını sağlamalı, sağlık çalışanlarını riske sokmadan planlanmalıdır. Ancak onkolojik ve cerrahi sonuçların bu yapılacak tedavi değişikliklerinden etkilenmemesi ana amaç olmalıdır. Bu çalışmada, kişiselleştirilmiş tedavi ile güncel uluslararası kılavuzlar da tartışılarak, pandemi döneminde kolorektal kanserin cerrahi, kemoterapi, radyoterapi seçenekleri kullanılarak multimodal tedavisinin nasıl planlanacağı tartışılmıştır.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30.
- Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2012;131:1649- 1658.
- ACS. ACS Risk Calculator - Home Page [Internet]. 2019 [cited 2020 Apr 6]. Available from: https://riskcalculator.facs.org/RiskCalculator/
- Urgent Intercollegiate General Surgery Guidance on COVID-19 | ACPGBI [Internet]. [cited 2020 Mar 29]. Available from: https://www.acpgbi.org. uk/news/urgent-intercollegiate-general-surgery-guidance-on-covid-19/
- COVID-19 Guidelines for Triage of Colorectal Cancer Patients. [cited 2020 Mar 29]; Available from: https://www.facs.org/covid-19/clinical-guidance/ elective-case/colorectal-cancer
- Considerations for Multidisciplinary Management of Patients with Colorectal Cancer during the COVID- 19 Pandemic. [cited 2020 Mar 29];(5962281):1–10. Available from: https://www.acpgbi.org.uk/news/ considerations-for-multidisciplinary-management-of-patients-withcolorectal-cancer-during-the-covid-19-pandemic/acpgbi-statement-oncrc-treatment-during-covid-19-final/
- SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis - SAGES [Internet]. [cited 2020 Mar 30]. Available from: https://www.sages.org/recommendations-surgical-response-covid-19/
- Lee YH, Kung PT, Wang YH, Kuo WY, Kao SL, Tsai WC. Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study. PLoS One 2019;14:e0210465.
- Strous MTA, Janssen-Heijnen MLG, Vogelaar FJ. Impact of therapeutic delay in colorectal cancer on overall survival and cancer recurrence – is there a safe timeframe for prehabilitation? Eur J Surg Oncol 2019;45:2295- 2301.
- Wanis KN, Patel SVB, Brackstone M. Do moderate surgical treatment delays influence survival in colon cancer? Dis Colon Rectum 2017;60:1241-1249.
- Flemming JA, Nanji S, Wei X, Webber C, Groome P, Booth CM. Association between the time to surgery and survival among patients with colon cancer: A population-based study. Eur J Surg Oncol 2017;43:1447-1455.
- Kucejko RJ, Holleran TJ, Stein DE, Poggio JL. How Soon Should Patients With Colon Cancer Undergo Definitive Resection? Dis Colon Rectum 2020;63:172-182.
- Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 2009;96:10-10.
- Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 2012;23:2731-2737.
- Pellino G, Spinelli A. How COVID-19 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond Infection. Dis Colon Rectum 2020;Available from: http://www.ncbi.nlm.nih.gov/pubmed/32205796
- Fernández-Martos C, Garcia-Albeniz X, Pericay C, Maurel J, Aparicio J, Montagut C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial. Ann Oncol 2015;26:1722-8.
- Resource for Management Options of Colorectal Cancer During COVID-19 [Internet]. [cited 2020 Mar 30]. Available from: https://www. surgonc.org/wp-content/uploads/2020/03/Colorectal-Resource-duringCOVID-19-3.23.20.pdf
- Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-1223.
- Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012;30:3827-3833.
- Visser MR, van Lanschot JJ, van der Velden J, Kloek JJ, Gouma DJ SM. Quality of Life in Newly Diagnosed Cancer Patients Waiting for Surgery is Seriously Impaired. J Surg Oncol 2006;93:571-577.
- Bhandari A, Woodhouse M, Gupta S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: A SEER-based analysis with comparison to other young-onset cancers. J Investig Med 2017;65:311-315.
- Kamer E, Çolak T. What to Do When A Patient Infected With COVID-19 Needs An Operation: A Pre-surgery, Peri-surgery and Post-surgery Guide. Turk J Color Dis 2020;30:1-8.
- Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-574.
- Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 ;[cited 2020 Mar 29];NEJMoa2002032. Available from: http://www.nejm.org/doi/10.1056/ NEJMoa2002032
- Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARSCoV-2 in Different Types of Clinical Specimens. Jama 2020;doi: 10.1001/ jama.2020.3786. [Epub ahead of print].
- Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med 1998;23:172-174.
- Hensman C, Baty D, Willis RG, Cuschieri A. Chemical composition of smoke produced by high frequency electrosurgery in a closed gaseous environment: An in vitro study. Surg Endosc 1998;12:1017-1019.
- Johnson GK, Robinson WS. Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments. J Med Virol 1991;33:47-50.
- Zheng MH, Boni L, Facs MD, Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy. Ann Surg 2020 Mar 26. doi: 10.1097/SLA.0000000000003924. [Epub ahead of print].
- Resources for Smoke & Gas Evacuation During Open, Laparoscopic, and Endoscopic Procedures - SAGES [Internet]. [cited 2020 Mar 30]. Available from: https://www.sages.org/resources-smoke-gas-evacuation-duringopen-laparoscopic-endoscopic-procedures/
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394- 424.
| APA | Akyol C, KOÇ M, utkan g, Yildiz F, Kuzu A (2020). The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. , 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| Chicago | Akyol Cihangir,KOÇ MEHMET ALI,utkan gungor,Yildiz Ferah,Kuzu Ayhan The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. (2020): 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| MLA | Akyol Cihangir,KOÇ MEHMET ALI,utkan gungor,Yildiz Ferah,Kuzu Ayhan The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. , 2020, ss.67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| AMA | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. . 2020; 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| Vancouver | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. . 2020; 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| IEEE | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A "The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?." , ss.67 - 75, 2020. 10.4274/tjcd.galenos.2020.2020-4-11 |
| ISNAD | Akyol, Cihangir vd. "The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?". (2020), 67-75. https://doi.org/10.4274/tjcd.galenos.2020.2020-4-11 |
| APA | Akyol C, KOÇ M, utkan g, Yildiz F, Kuzu A (2020). The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi, 30(2), 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| Chicago | Akyol Cihangir,KOÇ MEHMET ALI,utkan gungor,Yildiz Ferah,Kuzu Ayhan The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi 30, no.2 (2020): 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| MLA | Akyol Cihangir,KOÇ MEHMET ALI,utkan gungor,Yildiz Ferah,Kuzu Ayhan The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi, vol.30, no.2, 2020, ss.67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| AMA | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi. 2020; 30(2): 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| Vancouver | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?. Türk Kolon ve Rektum Hastalıkları Dergisi. 2020; 30(2): 67 - 75. 10.4274/tjcd.galenos.2020.2020-4-11 |
| IEEE | Akyol C,KOÇ M,utkan g,Yildiz F,Kuzu A "The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?." Türk Kolon ve Rektum Hastalıkları Dergisi, 30, ss.67 - 75, 2020. 10.4274/tjcd.galenos.2020.2020-4-11 |
| ISNAD | Akyol, Cihangir vd. "The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?". Türk Kolon ve Rektum Hastalıkları Dergisi 30/2 (2020), 67-75. https://doi.org/10.4274/tjcd.galenos.2020.2020-4-11 |
